Latest News - CRSTodayEurope

Friday, February 17, 2017 | Clinical Trials, Product Releases, Pixium Vision

Pixium Vision Announces First Implantation and Activation of IRIS II in Spain

Pixium Vision announced the first implantation and activation of IRIS II in Spain. This implantation is part of Pixium Vision’s ongoing multicenter clinical trial to assess the performance of IR…

Read the full story

Friday, February 17, 2017 | Medical Studies

Patient Complaints ID Surgeons With More Postop Complications

Patients whose surgeons have high numbers of patient complaints are at increased risk for postoperative complications compared with those whose surgeons have fewer patient complaints, according to a s…

Read the full story

Thursday, February 16, 2017 | Product Releases, Imprimis Pharmaceuticals

Imprimis Pharmaceuticals Begins Dispensing from FDA-Registered 503B Outsourcing Facility

Imprimis Pharmaceuticals announced that it has begun shipping its core sterile ophthalmic medications to select customers from its FDA-registered outsourcing facility without the need for a patient-sp…

Read the full story

Thursday, February 16, 2017 | Awards

ASCRS Announces 2017 Ophthalmology Hall of Fame Inductees

The American Society of Cataract and Refractive Surgery (ASCRS) has announced that it will induct Gullapalli N. Rao, MD, and the late Karl Koller, MD, into the ASCRS Ophthalmology Hall of Fame on Satu…

Read the full story

Thursday, February 16, 2017 | Clinical Trials, Glaukos Corporation

Glaukos Completes Patient Enrollment in Pivital Phase of US IDE Clinical Trial for iStent Supra

Glaukos announced the completion of patient enrollment in the pivotal phase of its FDA investigational device exemption (IDE) trial for the iStent Supra Suprachoroidal Micro-Bypass Stent. The iSten…

Read the full story

Wednesday, February 15, 2017 | Medical Studies

FDA Revises Bioequivalence Guidance for Generic Durezol Following Novartis Petition

The FDA on Tuesday revised its draft bioequivalence (BE) guidance detailing the agency's expectations for generic versions of Durezol (difluprednate ophthalmic emulsion) in response to a citizen p…

Read the full story

Wednesday, February 15, 2017 | Awards

Himalayan Cataract Project Semifinalist for $100 Million Grant

The Himalayan Cataract Project is one of eight groups named as semifinalists in "100&Change," a global competition for a single $100 million grant from the John D. and Catherine T. MacAr…

Read the full story

Wednesday, February 15, 2017 | Product Releases

Visiometrics Launches New Website

Visiometrics has launched a newly designed website at www.Visiometrics.com, showcasing its ophthalmic diagnostic technology. The new site improves the customer experience with access to video and acad…

Read the full story

Wednesday, February 15, 2017 | Management/Leadership

Sight Sciences Announces Major Expansion of Management Team

Sight Sciences announced an expansion of its management team to support its recent regulatory milestones and commercial success. New hires include Anne-Marie Ripley, Vice President of Clinical and Reg…

Read the full story

Tuesday, February 14, 2017 | Glaucoma, Allergan

Allergan Announces First Commercial Use of XEN Glaucoma Treatment System in the US

Allergan announced that its XEN Glaucoma Treatment System is now being used by US surgeons to treat refractory glaucoma. The XEN Glaucoma Treatment System, consisting of the XEN45 Gel Stent and the XE…

Read the full story

Tuesday, February 14, 2017 | Medical Studies

Novice Cataract Surgeons May Be Prone to Complications During Independent Practice

First-year cataract surgeons are nine times more likely to have high complication rates than more experienced surgeons, suggesting better training and monitoring may be needed, researchers in Canada s…

Read the full story

Tuesday, February 14, 2017 | Earnings & Financials

Teva Said to Consider Options for Branded Generics Unit

Israeli drugmaker Teva Pharmaceutical Industries is weighing options including a sale of its branded generics products business as it works to reduce debt, according to people familiar with the m…

Read the full story

Monday, February 13, 2017 | Acquisitions/Mergers, Allergan

Allergan to Acquire Zeltiq, Maker of CoolSculpting System, for $2.47 Billion

Allergan has agreed to acquire Zeltiq Aesthetics for $56.50 per share, or $2.475 billion, subject to customary adjustments, the companies announced in a news release. T Allergan said the acquisitio…

Read the full story

Monday, February 13, 2017 | Earnings & Financials, Bausch+Lomb

Bausch + Lomb Ends Unilateral Pricing Policy

Bausch + Lomb became the latest contact lens company to move away from its Unilateral Pricing Policy (UPP) with the announcement late Friday that a “competitive imbalance” had forced the c…

Read the full story

Monday, February 13, 2017 | Medical Studies

Laundry Pods Cause Large Portion Of Chemical Eye Burns in Kids

As concentrated laundry detergent pods have become more common, so have chemical eye injuries among young children, according to a recent U.S. study. The small, colorful packets of detergent were resp…

Read the full story
Load More